People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · AI / ML, Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Clinigence Holdings, Inc. | — | AI / ML | Growth/Late | $2.5B | $56.0M | 2018 |
| Apollo Medical Holdings, Inc. | — | Healthtech | Series D+ | $312.8M | $11.2M | 2009 |
| Cardio Diagnostics Inc. | — | Biotechnology | Series A | $13.2M | $94.2M | 2021 |
| Vesicor Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $715K | $2.4M | 2024 |
Warren Hosseinion at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Warren Hosseinion on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mihir Shah | 2 | 7 |
| Michael Bowen | 2 | 6 |
| Warren Hosseinionn | 2 | 3 |
| Elisa Luqman | 2 | 3 |
| Mark Fawcett | 2 | 2 |
| Eric Chin | 1 | 17 |
| MICHAEL CHANG | 1 | 13 |
| David Schmidt | 1 | 7 |
| Matthew Young | 1 | 7 |
| Oded Levy | 1 | 4 |
| Robert Philibert | 1 | 2 |
| Meeshanthini Dogan | 1 | 2 |
| Albert Young | 1 | 2 |
| Kenneth Sim | 1 | 2 |
| Lawrence Schimmel | 1 | 2 |
| Martin Breslin | 1 | 2 |
| Mark Meyers | 1 | 2 |
| Richard Chan | 1 | 2 |
| Linda Marsh | 1 | 2 |
| Michael Reed | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.